4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board
July 13, 2020 07:00 ET
|
4Bio Capital
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board Professor of Microbiology and Immunology at Keio UniversityBrings extensive experience in gut microbiota, a...
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board
July 13, 2020 02:00 ET
|
4Bio Capital
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board Professor of Microbiology and Immunology at Keio UniversityBrings extensive experience in gut microbiota, a...
4BIO Capital appoints Brian P. McVeigh as Venture Partner
July 01, 2020 07:00 ET
|
4Bio Capital
Press Release 4BIO Capital appoints Brian P. McVeigh as Venture Partner Appointment of seasoned pharma and biotech industry veteran to strengthen 4BIO Capital’s US operations 1 July 2020 LONDON...
4BIO Capital appoints Brian P. McVeigh as Venture Partner
July 01, 2020 02:00 ET
|
4Bio Capital
Press Release 4BIO Capital appoints Brian P. McVeigh as Venture Partner Appointment of seasoned pharma and biotech industry veteran to strengthen 4BIO Capital’s US operations 1 July 2020 LONDON...
4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin
June 08, 2020 07:00 ET
|
4Bio Capital
Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...
4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin
June 08, 2020 02:00 ET
|
4Bio Capital
Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...
4BIO Capital portfolio company ADC Therapeutics SA closes an upsized IPO of over $267.6 million
May 20, 2020 07:00 ET
|
4Bio Capital
Press Release 4BIO Capital portfolio company ADC Therapeutics SA closes an upsized IPO of over $267.6 million 20 May 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the...
4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A
March 25, 2020 07:03 ET
|
4Bio Capital
Press Release 4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A Pioneering chemogenetics company is one of the first investments from 4BIO Capital’s Ventures II fund 25 March 2020 ...
4BIO Capital raises $50 million in first close of new advanced therapies fund
September 09, 2019 07:00 ET
|
4Bio Capital
Press Release 4BIO Capital raises $50 million in first close of new advanced therapies fund 4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final...
4BIO Capital raises $50 million in first close of new advanced therapies fund
September 09, 2019 02:00 ET
|
4Bio Capital
Press Release 4BIO Capital raises $50 million in first close of new advanced therapies fund 4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final...